VIJAYA - Vijaya Diagnostic Centre Limited Share Price

Healthcare Services

₹1033.40-5.00(-0.48%)

Market Open as of Apr 28, 2025, 14:00 IST

What does Vijaya Diagnostic Centre Limited do?

Healthcare Service Provider•Healthcare•Small Cap

Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

Industry Group:Healthcare Services

Employees:2,053

Website:www.vijayadiagnostic.com

Summary of Latest Earnings Report from Vijaya Diagnostic Centre

Summary of Vijaya Diagnostic Centre's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated: Feb 25

Management Outlook and Major Points:

Outlook:

Aggressive Expansion: Commissioning 6 new hubs in Pune, Bengaluru, and West Bengal within 3 months, totaling 9 hubs added in 12 months. Three more leases finalized in West Bengal for future hubs.
Geographic Growth: Focus on replicating dense network success in new regions (Bengaluru, Pune, Kolkata) and strengthening presence in core markets (AP/Telangana).
Technology & Efficiency: Continued IT investments to enhance customer experience and operational efficiency, including CRM implementation.
Margin Impact: Near-term EBITDA margins may dip slightly due to new hub investments but expected to normalize post-ramp-up (6"“12 months for breakeven).
Talent & Leadership: Strategic hires and internal promotions to support growth.

Key Highlights:

Financial Performance: Q3 revenue grew 27% YoY (20% organic), with EBITDA up 28% (39.7% margin). PAT rose 36% (21% margin).
Volume-Driven Growth: Test volumes surged 27% YoY; B2C revenue remained robust at 93% of total.
PH Diagnostics Integration: Pune contributed INR 11 crore in Q3 (~INR 47 crore annual run rate), with margins stabilizing at ~39% YTD.
Capital Allocation: INR 200 crore capex budget for 12 hubs; pay-per-use model for PET-CT in Tirupati to optimize costs.
Market Leadership: Sustained as largest B2C integrated diagnostic chain with strong brand recall and high return ratios.

Challenges:

Currency volatility (USD/INR) may marginally impact reagent costs (~0.3% EBITDA).
New GST regulations on leases added ~0.3% cost in Q3.

Growth Drivers:

Volume-led organic expansion, hub-spoke model scalability, and preventive healthcare demand (wellness segment at ~14% of revenue).

Q&A Session

Last updated: Feb 25

Question 1: Can you give a breakdown of the overall center count? How many are in Hyderabad and the rest of AP & Telangana?
Answer: As of Q3 FY25, Vijaya has 149 centers: 127 in Telangana/AP, 18 in Pune, 2 in Kolkata, 1 in Karnataka, and 1 in NCR.

Question 2: When will Gulbarga and Ongole centers breakeven?
Answer: Gulbarga achieved breakeven in Q3. Ongole is expected to breakeven within the next 2 months.

Question 3: Should we expect volume growth to remain at current levels with expansion?
Answer: Guidance targets ~15% annual growth, with ~13% from volume and ~2% from value. Expansion in new hubs and geographies will support this.

Question 4: How does the hub addition plan (12 hubs over FY25"“26) align with capex?
Answer: Capex remains unchanged at INR 200 crore for 12 hubs. Three hubs added in 9M FY25; 6 more to open in the next 3 months. Additional leases in AP/Telangana will follow.

Question 5: Why is Bangalore expansion faster than Pune?
Answer: Faster execution in Bangalore due to strategic location selection, vendor experience from Kolkata/Pune, and proximity to Hyderabad.

Question 6: What is the USD/INR depreciation impact?
Answer: Potential 0.2"“0.4% EBITDA impact via reagent costs. Equipment procurement costs may rise but remain manageable.

Question 7: What are PH Pune's margins and growth outlook?
Answer: PH Pune's Q3 EBITDA margin was 36% (9M: 39%). Margins may dip temporarily due to new hub investments; base business targets 38"“40%.

Question 8: How will margin leverage play out amid expansion?
Answer: Near-term margin pressure (1"“2%) from new hubs and GST changes. Operating leverage will normalize post stabilization (~1 year).

Question 9: Are you gaining market share in core geographies?
Answer: Yes, due to brand strength, dense networks, and advanced technology. Growth outpaces smaller competitors.

Question 10: What drives wellness segment growth?
Answer: Increased preventive healthcare demand post-COVID. Q4 typically sees higher wellness revenue due to corporate tax exemptions.

Question 11: What is the net cash position?
Answer: Surplus cash stands at ~INR 200 crore.

Question 12: Is mid-teens revenue guidance conservative given hub additions?
Answer: Guidance factors new geographies' uncertain ramp-up. Core AP/Telangana hubs drive growth; new regions may exceed expectations.

Question 13: What are pre-IndAS margins?
Answer: Pre-IndAS EBITDA margin is ~33.5% (vs. 40% under IndAS). PAT margin improves by ~1% (to 22%) excluding rent accounting.

Pros

Growth: Good revenue growth. With NA% growth over past three years, the company is going strong.

Balance Sheet: Strong Balance Sheet.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Size: Market Cap wise it is among the top 20% companies of india.

Profitability: Very strong Profitability. One year profit margin are 21%.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Technicals: Bullish SharesGuru indicator.

Cons

No major cons observed.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Sector Comparison: VIJAYA vs Healthcare Services

Comprehensive comparison against sector averages

Comparative Metrics

VIJAYA metrics compared to Healthcare

Category	VIJAYA	Healthcare
PE	74.73	64.54
PS	15.69	7.07
Growth	26.8 %	4.9 %

Performance Comparison

VIJAYA vs Healthcare (2022 - 2025)

Key Insights

1. VIJAYA is among the Top 3 Healthcare Service Provider companies by market cap.
2. The company holds a market share of 9.3% in Healthcare Service Provider.
3. In last one year, the company has had an above average growth that other Healthcare Service Provider companies.

Share Holdings

Understand Vijaya Diagnostic Centre ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

As of 2025-03-31

Shareholder Name	Holding %
SURENDRANATH REDDY SURA	32.31%
SUPRITA S REDDY	8.74%
SUNIL CHANDRA KONDAPALLY	7.98%
KOTAK SMALL CAP FUND	5.74%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA NIF	5.1%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL F	4.01%
GEETHA REDDY SURA	3.95%
WASATCH EMERGING INDIA FUND	2.24%
THE INDIA FUND INC	1.55%
HSBC SMALL CAP FUND	1.46%
ABERDEEN NEW INDIA INVESTMENT TRUST PLC	1.44%
ABRDN ASIA FOCUS PLC	1.25%
MOTILAL OSWAL NIFTY SMALLCAP 250 INDEX FUND	1.07%
THE PRUDENTIAL ASSURANCE COMPANY LIMITED	1.06%
BIRUDAVOLU VISHNU PRIYA	0.03%
VENKATA SANJAY KUMAR PULIGORU	0.01%
P MADHULIKA	0.01%
BIRUDAVOLU GAUTAM	0.01%
VIJAYA HOLDINGS INDIA LLP	0%
BIRUDAVOLU CHARITHA REDDY	0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Valuation
Market Cap	10.66 kCr
Price/Earnings (Trailing)	74.73
Price/Sales (Trailing)	15.69
EV/EBITDA	37.59
Price/Free Cashflow	109.45
MarketCap/EBT	56.19

Fundamentals
Revenue (TTM)	679.37 Cr
Rev. Growth (Yr)	26.04%
Rev. Growth (Qtr)	-7.35%
Earnings (TTM)	142.61 Cr
Earnings Growth (Yr)	35.76%
Earnings Growth (Qtr)	-16.2%

Profitability
Operating Margin	27.92%
EBT Margin	27.92%
Return on Equity	19.59%
Return on Assets	12.67%
Free Cashflow Yield	0.91%

Investor Care
Dividend Yield	0.19%
Dividend/Share (TTM)	2
Shares Dilution (1Y)	0.31%
Diluted EPS (TTM)	13.81

Financial Health
Current Ratio	2.36
Debt/Equity	0.00
Debt/Cashflow	0.00

Is Vijaya Diagnostic Centre Better than it's peers?

Detailed comparison of Vijaya Diagnostic Centre against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
APOLLOHOSP	Apollo Hospitals EnterprisesHospital	99.74 kCr	21.31 kCr	+6.39%	+8.65%	73.93	4.68	+15.13%	+64.06%
FORTIS	Fortis HealthcareHospital	49.42 kCr	7.62 kCr	+1.39%	+47.16%	59.94	6.49	+12.17%	+42.06%
LALPATHLAB	Dr. Lal PathlabsHealthcare Service Provider	23.62 kCr	2.49 kCr	+15.42%	+21.22%	55.89	9.48	+11.31%	+26.72%
METROPOLIS	Metropolis HealthcareHealthcare Service Provider	8.99 kCr	1.33 kCr	+11.02%	-1.05%	58.82	6.77	+13.76%	+21.84%
THYROCARE	Thyrocare TechHealthcare Service Provider	4.78 kCr	668.16 Cr	+25.81%	+36.75%	44.6	7.16	+18.66%	+65.42%

Balance Sheet for Vijaya Diagnostic Centre

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	-33.3%	11	16	21	23	18	10
Current investments	45.4%	158	109	195	139	84	54
Loans, current	-	0	0	0	0	0.96	1.05
Total current financial assets	33.9%	250	187	303	263	256	256
Inventories	33.7%	5.56	4.41	3.55	1.93	4.35	4.1
Total current assets	32.8%	260	196	312	270	266	264
Property, plant and equipment	7.6%	611	568	548	282	466	351
Capital work-in-progress	108.3%	16	8.2	15	249	8.55	34
Investment property	0%	11	11	11	11	11	11
Non-current investments	0%	144	144	4.87	4.87	4.87	4.87
Loans, non-current	25%	16	13	5.75	5.75	5.75	5.75
Total non-current financial assets	3%	172	167	20	19	19	18
Total non-current assets	7.2%	821	766	610	580	530	446
Total assets	12.4%	1,081	962	922	850	797	711
Total non-current financial liabilities	5.6%	246	233	239	233	216	170
Provisions, non-current	13.8%	11	9.79	9.02	6.84	7.28	7.12
Total non-current liabilities	6.2%	258	243	248	240	224	178
Total current financial liabilities	62.1%	95	59	68	55	61	57
Provisions, current	14%	2.79	2.57	2.38	3.35	2.59	1.55
Current tax liabilities	38100%	4.8	0.99	3.01	2.35	3.6	0.9
Total current liabilities	63.1%	107	66	77	65	71	63
Total liabilities	18.2%	365	309	325	305	295	241
Equity share capital	0%	10	10	10	10	10	10
Total equity	9.7%	716	653	596	545	501	470
Total equity and liabilities	12.4%	1,081	962	922	850	797	711

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	-33.3%	15	22	23	24	19	11
Current investments	47.2%	160	109	195	139	84	54
Total current financial assets	30.3%	263	202	310	269	262	262
Inventories	34.9%	6.64	5.18	3.69	2.05	4.52	4.28
Total current assets	30.5%	275	211	319	276	272	270
Property, plant and equipment	10.3%	664	602	561	294	479	364
Capital work-in-progress	135.8%	18	8.21	15	249	8.55	34
Goodwill	0%	119	119	5.34	5.34	5.34	5.34
Non-current investments	0%	0.04	0.04	0.04	0.04	0.04	0.04
Total non-current financial assets	40%	15	11	9.76	9.04	8.1	7.59
Total non-current assets	10.4%	851	771	608	578	527	444
Total assets	14.5%	1,125	983	926	853	799	713
Total non-current financial liabilities	12.6%	269	239	239	233	216	0
Provisions, non-current	10%	12	11	9.19	7.12	7.59	7.42
Total non-current liabilities	12.4%	281	250	248	241	224	178
Borrowings, current	-	0	0	0	0	0.11	0.63
Total current financial liabilities	61.9%	103	64	69	56	63	47
Provisions, current	7.4%	3.32	3.16	2.98	3.95	3.14	2.09
Current tax liabilities	1961.9%	5.33	1.21	2.97	2.41	3.6	0.9
Total current liabilities	59.7%	116	73	79	66	73	66
Total liabilities	23%	397	323	327	307	298	244
Equity share capital	0%	10	10	10	10	10	10
Non controlling interest	20.3%	3.07	2.72	2.33	1.9	1.57	1.32
Total equity	10.3%	728	660	599	547	502	470
Total equity and liabilities	14.5%	1,125	983	926	853	799	713

Cash Flow for Vijaya Diagnostic Centre

Consolidated figures (in Rs. Crores) / View Standalone Data

Finance costs	16.7%
Change in inventories	-368.3%
Depreciation	-8.2%
Impairment loss / reversal	-5100%
Adjustments for interest income	-31.7%
Share-based payments	75%
Net Cashflows from Operations	13.7%
Income taxes paid (refund)	32%
Net Cashflows From Operating Activities	11%
Cashflows used in obtaining control of subsidiaries	-
Proceeds from sales of PPE	410.7%
Purchase of property, plant and equipment	-29.8%
Proceeds from sales of long-term assets	-101.1%
Interest received	18.4%
Other inflows (outflows) of cash	-
Net Cashflows From Investing Activities	-29.6%
Proceeds from issuing other equity instruments	-725%
Proceeds from exercise of stock options	-
Repayments of borrowings	-170.3%
Payments of lease liabilities	-
Dividends paid	0%
Interest paid	-1%
Net Cashflows from Financing Activities	-6.2%
Net change in cash and cash eq.	-138%

Standalone figures (in Rs. Crores) / View Consolidated Data

Finance costs	16.7%
Change in inventories	-397.4%
Depreciation	-10%
Adjustments for interest income	-29.1%
Share-based payments	75%
Net Cashflows from Operations	10.1%
Income taxes paid (refund)	28%
Net Cashflows From Operating Activities	7.4%
Cashflows used in obtaining control of subsidiaries	-
Proceeds from sales of PPE	348.6%
Purchase of property, plant and equipment	-30.9%
Proceeds from sales of long-term assets	-101.1%
Purchase of other long-term assets	-
Cash receipts from repayment of advances and loans made to other parties	-
Interest received	13.2%
Other inflows (outflows) of cash	12912.5%
Net Cashflows From Investing Activities	-28%
Proceeds from issuing other equity instruments	-725%
Proceeds from exercise of stock options	-
Payments of lease liabilities	-
Dividends paid	0%
Net Cashflows from Financing Activities	-4.9%
Net change in cash and cash eq.	-172.8%

Income Statement for Vijaya Diagnostic Centre

Standalone figures (in Rs. Crores) / View Consolidated Data

QuarterlyAnnual

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-7.7%	156	169	142	141	129	136
Other Income	5%	4.99	4.8	3.83	3.41	5.25	6.92
Total Income	-7%	161	173	146	144	134	143
Cost of Materials	-5%	20	21	17	17	16	16
Employee Expense	4.2%	26	25	25	22	22	21
Finance costs	3.7%	6.26	6.07	6.05	5.95	6.05	5.84
Depreciation and Amortization	14.3%	17	15	15	15	14	14
Other expenses	-7.8%	48	52	45	44	40	42
Total Expenses	-2.5%	117	120	108	105	98	99
Profit Before exceptional items and Tax	-18.9%	44	54	38	40	36	44
Exceptional items before tax	-	0	0	0	0	-2.05	0
Total profit before tax	-18.9%	44	54	38	40	34	44
Current tax	-30.5%	8.64	12	8.69	7.31	9.07	8.62
Deferred tax	19.4%	2.17	1.98	0.76	1.98	-0.48	2.32
Total tax	-23.1%	11	14	9.45	9.29	8.59	11
Total profit (loss) for period	-15.4%	34	40	29	31	25	33
Other comp. income net of taxes	0%	-0.03	-0.03	-0.03	-0.27	0.05	0.05
Total Comprehensive Income	-13.2%	34	39	29	30	25	33
Earnings Per Share, Basic	-20.7%	3.26	3.85	2.82	2.98	2.47	3.21
Earnings Per Share, Diluted	-20.4%	3.26	3.84	2.81	2.97	2.46	3.2

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Revenue From Operations	16.7%	525	450	451
Other Income	42.9%	21	15	13
Total Income	17.7%	546	464	464
Cost of Materials	8.8%	63	58	69
Employee Expense	13.3%	86	76	69
Finance costs	15%	24	21	16
Depreciation and Amortization	-10%	55	61	52
Other expenses	19.9%	164	137	113
Total Expenses	11.1%	392	353	319
Profit Before exceptional items and Tax	40%	155	111	144
Exceptional items before tax	-	-2.05	0	0
Total profit before tax	37.3%	152	111	144
Current tax	14.8%	32	28	39
Deferred tax	1073.5%	5.77	0.51	-2.53
Total tax	37%	38	28	36
Total profit (loss) for period	39%	115	83	108
Other comp. income net of taxes	-38.3%	-0.12	0.19	0.19
Total Comprehensive Income	37.8%	114	83	108
Earnings Per Share, Basic	42.6%	11.21	8.16	10.6
Earnings Per Share, Diluted	43%	11.18	8.12	10.54

Consolidated figures (in Rs. Crores) / View Standalone Data

QuarterlyAnnual

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-7.7%	169	183	156	155	133	139
Other Income	5.4%	4.7	4.51	3.56	3.25	5.11	6.75
Total Income	-7%	174	187	160	158	138	146
Cost of Materials	-9.1%	21	23	19	19	16	16
Employee Expense	3.7%	29	28	27	25	23	22
Finance costs	6.4%	6.82	6.47	6.27	6.19	6.06	5.85
Depreciation and Amortization	6.2%	18	17	17	16	15	14
Other expenses	-7.3%	52	56	49	49	41	43
Total Expenses	-2.3%	127	130	118	115	101	101
Profit Before exceptional items and Tax	-17.9%	47	57	42	44	37	45
Exceptional items before tax	-	0	0	0	0	-2.05	0
Total profit before tax	-17.9%	47	57	42	44	35	45
Current tax	-30.5%	9.34	13	9.61	8.2	9.23	8.67
Deferred tax	-14.5%	2.06	2.24	0.79	1.99	-0.46	2.34
Total tax	-28.6%	11	15	10	10	8.76	11
Total profit (loss) for period	-17.1%	35	42	32	34	26	34
Other comp. income net of taxes	0%	-0.03	-0.03	-0.03	-0.26	0.05	0.05
Total Comprehensive Income	-17.1%	35	42	31	33	26	34
Earnings Per Share, Basic	-21.7%	3.42	4.09	3.06	3.27	2.53	3.26
Earnings Per Share, Diluted	-21.4%	3.42	4.08	3.05	3.26	2.52	3.25

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Revenue From Operations	19.4%	548	459	462
Other Income	53.8%	21	14	13
Total Income	20.3%	569	473	475
Cost of Materials	10.3%	65	59	72
Employee Expense	15.6%	90	78	71
Finance costs	15%	24	21	16
Depreciation and Amortization	-8.2%	57	62	53
Other expenses	22.3%	171	140	117
Total Expenses	13.4%	408	360	328
Profit Before exceptional items and Tax	41.6%	161	114	147
Exceptional items before tax	-	-2.05	0	0
Total profit before tax	39.8%	159	114	147
Current tax	18.5%	33	28	40
Deferred tax	1152.2%	5.84	0.54	-2.83
Total tax	40.7%	39	28	37
Total profit (loss) for period	41.7%	120	85	111
Other comp. income net of taxes	-38.7%	-0.11	0.2	0.21
Total Comprehensive Income	41.7%	120	85	111
Earnings Per Share, Basic	45.7%	11.62	8.29	10.76
Earnings Per Share, Diluted	45.9%	11.59	8.26	10.69

VIJAYA - Vijaya Diagnostic Centre Limited Share Price

What does Vijaya Diagnostic Centre Limited do?

Summary of Latest Earnings Report from Vijaya Diagnostic Centre

Sector Comparison: VIJAYA vs Healthcare Services

Comparative Metrics

Performance Comparison

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Valuation

Fundamentals

Profitability

Investor Care

Financial Health

Is Vijaya Diagnostic Centre Better than it's peers?

Balance Sheet for Vijaya Diagnostic Centre

Cash Flow for Vijaya Diagnostic Centre

Income Statement for Vijaya Diagnostic Centre

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)